Is 2093-3 covered under CMS LCD or NCD policies?

Applicable CMS coverage references for 2093-3: Check your local MAC jurisdiction for specific Local Coverage Determinations (LCD) or National Coverage Determinations (NCD)..

2093-3 LOINC Code | Cholesterol [Mass/volume] in Serum or Plasma | Codes-For-MD

Q: What is the official clinical definition of LOINC code 2093-3?

The official clinical description for 2093-3 is: Cholesterol [Mass/volume] in Serum or Plasma.

Q: What are the billing guidelines and documentation requirements for 2093-3?

To properly bill 2093-3, medical providers must ensure clear documentation of medical necessity. Standard CMS/AMA documentation guidelines apply. Ensure all components of the encounter are clearly detailed in the patient chart.

Q: What modifiers are applicable when billing 2093-3?

Commonly accepted modifiers for 2093-3 include: Refer to NCCI edits and specific payer rules for allowable modifiers..

Official Clinical Definition

Cholesterol [Mass/volume] in Serum or Plasma

Code System

LOINC

Clinical Category

Laboratory

Effective Date

2020-01-01

Billing Guidelines & Coding Notes

Standard CMS and AMA billing guidelines apply for 2093-3. Ensure that the service or procedure performed is fully documented in the patient's medical record and meets all local coverage requirements.

Official Coding Guidelines

Select the appropriate code level based on medical decision making complexity or total time spent on the date of the encounter. Do not unbundle services that are integral to the primary procedure.

Documentation Checklist for Medical Necessity

To prevent RAC audits and ensure first-pass claim reimbursement, medical chart notes for 2093-3 must explicitly verify the following components:

Must document chief complaint, comprehensive history of present illness, relevant review of systems, physical examination findings, and a clear assessment/plan establishing medical necessity.

Allowed Modifiers

25, 59, 95, GA, GX, GY, GZ, Q6

CMS LCD / NCD Coverage

Check local MAC jurisdiction for active LCD/NCD coverage policies.

Educational Guide: Optimizing 2093-3 in RCM

Proper utilization of 2093-3 (Cholesterol [Mass/volume] in Serum or Plasma) is critical for maintaining a healthy practice revenue cycle. Under-coding this service leads to significant revenue leakage, while over-coding or failing to meet NCCI edit standards triggers immediate payer denials and potential compliance audits.

When integrating 2093-3 into your superbills or EHR templates, ensure that your clinical staff correlates the diagnosis codes (ICD-10) to support the precise medical necessity of the procedure. Utilizing an automated claim scrubbing solution like Codes-For-MD's AI RCM platform guarantees that modifier combinations are validated prior to clearinghouse transmission.

Frequently Asked Questions about 2093-3

The official clinical description for 2093-3 is: Cholesterol [Mass/volume] in Serum or Plasma. This code is used by healthcare providers to classify the specific service, procedure, or diagnosis for medical billing.

To properly bill 2093-3, medical providers must ensure clear documentation of medical necessity. Standard CMS/AMA documentation guidelines apply. Ensure all components of the encounter are clearly detailed in the patient chart.

Commonly accepted modifiers for 2093-3 include: Refer to NCCI edits and specific payer rules for allowable modifiers.. Modifiers are used to indicate that a service or procedure was altered by some specific circumstance but not changed in its definition or code.

Codes-For-MD AI utilizes advanced NLP and machine learning to pre-scrub claims containing 2093-3, verifying correct modifier usage, NCCI edit compliance, and LCD/NCD medical necessity rules before submission to prevent claim denials.